Records containing: Malignancy
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-06-15Feasibility Study of Intra-Tumoral Lipopolysaccharide Immunotherapy for Intra-Abdominal Tumors
-
CLINICAL_TRIALS study record update · 2026-04-27Randomized Trial of Recruitment Strategies for Early Phase Therapeutic Cancer Trials
-
CLINICAL_TRIALS study record update · 2026-04-24Community Health Worker Based Intervention to Improve Palliative Care
-
CLINICAL_TRIALS study record update · 2026-04-24Targeted Oncolytic Virotherapy and Natural History Study of KSHV-Associated Multicentric Castleman's Disease With Laboratory and Clinical Correlates of Disease Activity
-
CLINICAL_TRIALS study record update · 2026-04-07Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-06Assessment of the Impact of Increased Production of Reactive Oxygen Species Produced During Repeated Sessions of Hyperbaric Oxygen Therapy in Patients Undergoing Radiotherapy for Neoplasia, on the Occurrence of DNA Damage
-
CLINICAL_TRIALS study record update · 2026-03-06Randomized Trial of Recruitment Strategies for Early Phase Therapeutic Cancer Trials
-
CLINICAL_TRIALS study record update · 2026-02-24A Project to Enhance Dermatology E-consultations in Primary Care Centers Using Artificial Intelligence Tools.
-
CLINICAL_TRIALS study record update · 2026-02-05Pediatric Patient-Reported Outcomes (PEPR) for Childhood Cancer Survivors: Clinical Validity Study
-
CLINICAL_TRIALS study record update · 2026-01-21Study Evaluating 68Ga-FAPI-46 Tumor Microenvironment Interaction in Solid Tumor Patients
-
CLINICAL_TRIALS study record update · 2026-01-13Comparative Outcomes of Chest Wall Reconstruction Using Twisted Steel Wires Versus Bone Cement: A Cohort Study
-
CLINICAL_TRIALS study record update · 2026-01-06Immune Reconstitution Monitoring and Pneumococcal Vaccination (PCV-21) in Patients Treated With Chimeric Antigen Receptor T-Cells
-
CLINICAL_TRIALS study record update · 2025-12-31Development and Clinical Translation of immunoPET Imaging Probes for Digestive System Carcinoma
-
CLINICAL_TRIALS study record update · 2025-11-24DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial): An Umbrella-Basket Platform Trial to Evaluate the Efficacy of Targeted Therapies in Rare Adult, Paediatric and Teenage/Young Adult (TYA) Cancers With Actionable Genomic Alterations, Including Common Cancers With Rare Actionable Alterations. Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.
-
CLINICAL_TRIALS study record update · 2025-11-24DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial): An Umbrella-Basket Platform Trial to Evaluate the Efficacy of Targeted Therapies in Rare Adult, Paediatric and Teenage/Young Adult (TYA) Cancers With Actionable Genomic Alterations, Including Common Cancers With Rare Actionable Alterations. Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High TMB or MSI-high or Proven CMMRD Disposition.
-
CLINICAL_TRIALS study record update · 2025-11-24DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial): An Umbrella-Basket Platform Trial to Evaluate the Efficacy of Targeted Therapies in Rare Adult, Paediatric and Teenage/Young Adult (TYA) Cancers With Actionable Genomic Alterations, Including Common Cancers With Rare Actionable Alterations. Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations
-
CLINICAL_TRIALS study record update · 2025-09-04Lineberger Comprehensive Cancer Center (LCCC) 1937: Immuno-Oncology Database and Bioregistry: Identifying Mechanisms of Autoimmune Diseases in the Era of Cancer Immunotherapy.
-
CLINICAL_TRIALS study record update · 2025-08-12Evaluation of the Effectiveness of Prophylactic Low Molecular Weight Heparin by Thromboelastography in Patients Who Underwent Lobectomy Due to Malignancy
-
CLINICAL_TRIALS study record update · 2025-07-24Tandem Polyurethane Stents Compared to Single Silicone Stent for Malignant Ureteral Obstruction
-
CLINICAL_TRIALS study record update · 2025-06-19A Non-Interventional Pragmatic Clinical Trial of NLP Models for the Detection of Immune-Related Adverse Events
-
CLINICAL_TRIALS study record update · 2025-02-10The Role of Stereo-tActic BoDy RadIotherApy iN Oligo-Progressive MalignanT Disease
-
CLINICAL_TRIALS study record update · 2024-12-27Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive Tumor
-
CLINICAL_TRIALS study record update · 2024-12-24A Multi-Center, Open Label Phase 1/2 Study of CYT-0851 in Patients With Relapsed/Refractory B-Cell Malignancies and Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2024-12-19DECOMPRESS (DECompressing Obstruction of Malignancy: Percutaneous Renal vs Endoscopic Stent)
-
CLINICAL_TRIALS study record update · 2024-12-10Feasibility Study of Intra-Tumoral Lipopolysaccharide Immunotherapy for Intra-Abdominal